Market Overview

Immunomedics Announces Results From Two Clinical Trials at Hematology Conference

Share:

Immunomedics, Inc. (Nasdaq: IMMU), today announced that two studies conducted by outside investigators that involved the Company's antibody drug candidates were presented at the 53^rd Annual Meeting of the American Society of Hematology.

Posted-In: News FDA

 

Related Articles (IMMU)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→